Medison logo

Medison

Asia, HaMerkaz, Israel, Petah Tiqva

Description

Medison is a pharma company that offers therapy products.

Investor Profile

Medison has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series C (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Medison frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
GH
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
Quark Venture
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
CH
North America, New York, United States, New York
Co-Investments: 1
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
AB
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
Partners Innovation Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2
Venrock
North America, California, United States, Palo Alto
Co-Investments: 1

What are some of recent deals done by Medison?

Keros Therapeutics

Lexington, Massachusetts, United States

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 4, 2020
Amount Raised: $56,000,000
Keros Therapeutics

Lexington, Massachusetts, United States

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BJan 8, 2019
Amount Raised: $23,000,000